OCLN and cancer: A more mesenchymal-like morphology (Fig. 1F), down-regulation of the epithelial marker Occludin (Fig. 1G), and increased expression of the mesenchymal markers α-SMA and Vimentin (Fig. 1G) were also seen in cancer cells.